StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
Calithera Biosciences has a 52 week low of $0.00 and a 52 week high of $0.12.
Calithera Biosciences Company Profile
See Also
- Five stocks we like better than Calithera Biosciences
- What is the Dogs of the Dow Strategy? Overview and Examples
- Constellation Powers Up With Reinforced AI Data Center Strategy
- Why Are These Companies Considered Blue Chips?
- Top Analyst-Rated Healthcare Stocks to Watch Now
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
